Liu Jia, Wei Bowen, Ma Qihong, Shi Danning, Pan Xue, Liu Zhenquan, Li Jian, Zhao Piwen
School of Life Sciences, Beijing University of Chinese Medicine, Beijing, 100029, China; School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, 100029, China.
School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, 100029, China; Department of Rheumatology and Immunology, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, 300193, China.
J Ethnopharmacol. 2024 Jan 10;318(Pt B):117023. doi: 10.1016/j.jep.2023.117023. Epub 2023 Aug 9.
Diminished ovarian reserve (DOR) was considered a refractory reproductive endocrine condition that negatively affected female reproductivity. Yangjing Zhongyu Decoction (YJZYD) had effects on treating infertility. However, there were few studies on the mechanisms of YJZYD preserving ovarian reserve.
To explore the possible mechanisms of YJZYD against DOR by UPLC-ESI-MS/MS, network pharmacology, and experimental validation.
The chemicals of YJZYD were measured by UPLC-ESI-MS/MS. The correlating targets of YJZYD and DOR were identified by the ETCM database, GeneCards database, and PubMed database. The common targets were employed with the DAVID database and visualized with the PPI network. GO and KEGG enrichment analyses were carried out to explore biological progression and pathways. In vivo experiments, energy production was assessed by ATP, and apoptosis rate was analyzed by TUNEL. The serum FSH, AMH, and E levels were evaluated by ELISA. Western blotting and immunohistochemistry were used to measure the expression of SIRT1, PGC1α, NRF1, COX IV, FSHR, CYP19A1, PI3K, p-Akt, Akt, Bcl-2, and Bax.
132 components in YJZYD were identified by UPLC-ESI-MS/MS. 149 overlapped targets were extracted from YJZYD and DOR, and the top 20 common targets included AKT1 and CYP19A1. ATP binding was involved in GO analysis. In the KEGG enrichment analysis, the metabolic pathway was the top, and the PI3K-Akt signaling pathway was included. In vivo experiments, YJZYD improved ovarian index and histomorphology. After YJZYD treatment, serum FSH, E, and AMH were well-modulated, and the content of ATP was up-regulated. Besides, the expression of Bax was suppressed in ovarian tissue, while the expressions of SIRT1, PGC1α, NRF1, COX IV, FSHR, CYP19A1, PI3K, Bcl-2, and p-Akt/Akt were enhanced.
YJZYD could attenuate reproductive endocrine disturbance and ovarian lesions in vivo by mediating steroidogenesis, energy metabolism, and cell apoptosis. This study uncovered the mechanisms of YJZYD against DOR, providing a theoretical basis for further study.
卵巢储备功能减退(DOR)被认为是一种难治性生殖内分泌疾病,对女性生殖能力有负面影响。养精种玉汤(YJZYD)对治疗不孕症有作用。然而,关于YJZYD保护卵巢储备功能机制的研究较少。
通过超高效液相色谱-电喷雾串联质谱(UPLC-ESI-MS/MS)、网络药理学和实验验证,探索YJZYD对抗DOR的可能机制。
采用UPLC-ESI-MS/MS测定YJZYD的化学成分。通过中药系统药理学数据库(ETCM)、基因卡片数据库(GeneCards)和PubMed数据库鉴定YJZYD和DOR的相关靶点。将共同靶点导入DAVID数据库并通过蛋白质-蛋白质相互作用(PPI)网络进行可视化。进行基因本体(GO)和京都基因与基因组百科全书(KEGG)富集分析,以探索生物学进程和信号通路。在体内实验中,通过三磷酸腺苷(ATP)评估能量产生,通过末端脱氧核苷酸转移酶介导的缺口末端标记法(TUNEL)分析细胞凋亡率。采用酶联免疫吸附测定(ELISA)法评估血清促卵泡生成素(FSH)、抗苗勒管激素(AMH)和雌二醇(E)水平。采用蛋白质免疫印迹法(Western blotting)和免疫组织化学法检测沉默信息调节因子1(SIRT1)、过氧化物酶体增殖物激活受体γ共激活因子1α(PGC1α)、核呼吸因子1(NRF1)、细胞色素C氧化酶亚基Ⅳ(COX Ⅳ)、促卵泡激素受体(FSHR)、细胞色素P450 19A1(CYP19A1)、磷脂酰肌醇-3激酶(PI3K)、磷酸化蛋白激酶B(p-Akt)、蛋白激酶B(Akt)、B细胞淋巴瘤/白血病-2(Bcl-2)和Bax的表达。
通过UPLC-ESI-MS/MS鉴定出YJZYD中的132种成分。从YJZYD和DOR中提取出149个重叠靶点,前20个共同靶点包括蛋白激酶B1(AKT1)和CYP19A1。GO分析涉及ATP结合。在KEGG富集分析中,代谢途径位居榜首,且包括PI3K-Akt信号通路。在体内实验中,YJZYD改善了卵巢指数和组织形态学。YJZYD治疗后,血清FSH、E和AMH得到良好调节,ATP含量上调。此外,卵巢组织中Bax的表达受到抑制,而SIRT1、PGC1α、NRF1、COX Ⅳ、FSHR、CYP19A1、PI3K、Bcl-2和p-Akt/Akt的表达增强。
YJZYD可通过介导类固醇生成、能量代谢和细胞凋亡减轻体内生殖内分泌紊乱和卵巢损伤。本研究揭示了YJZYD对抗DOR的机制,为进一步研究提供了理论依据。